Aspargo Labs uses a proprietary technology platform to reformulate oral medication to liquid doses. CEO and chairman Michael ...

Russell Bradley Named President & General Manager of CNSide Dr. Marc Hedrick, Rick Hawkins, and Russell Bradley Join CNSide ...

Some New York doctors are working on new ways to treat advanced cancers. Chimeric Antigen Receptor, or CAR, T-cell therapy ...

The firm will test additional doses and use its proprietary drug response predictor to gather data that can inform a registrational study.

Russell Bradley Named President & General Manager of CNSide Dr. Marc Hedrick, Rick Hawkins, and Russell Bradley Join CNSide Board of Directors Dr. Jonathan Stein Appointed CNSide Medical Director AUST ...

These drugs, discovered decades ago, continue to save lives today, but more recent research has led to the development of ...

Eligibility issues, a need for better multidisciplinary collaboration, and a lack of incorporation in community practices are ...

Adam Ratner predicts the appointment of anti-vaccine activist Robert F. Kennedy Jr. will impact vaccine availability and ...

Fact checked by Nick Blackmer A viral video that appears to show Robert F. Kennedy Jr. adding blue liquid to a drink has the ...

Million Private Placement Financing from Existing Investors$2.0 Million Funding Advance from the Cancer Prevention and Research Institute of ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system ...